Advanz Hits Back Over £100m+ Fines For UK Liothyronine Pricing

Firm ‘Utterly Disagrees’ With CMA And Vows To Appeal Decision

 
• By Dave Wallace
  
The CMA announced fines of more than £100m over liothyronine pricing • Source: Almy

More from United Kingdom

More from Europe